Literature DB >> 2552437

In vitro tyrosine phosphorylation studies on RAS proteins and calmodulin suggest that polylysine-like basic peptides or domains may be involved in interactions between insulin receptor kinase and its substrate.

Y Fujita-Yamaguchi1, S Kathuria, Q Y Xu, J M McDonald, H Nakano, T Kamata.   

Abstract

We have investigated the in vitro tyrosine phosphorylation of the HRAS and KRAS proteins by human placental insulin receptor kinase. Purified HRAS proteins are not phosphorylated by purified insulin receptor kinase. Since the tyrosine phosphorylation of calmodulin by the insulin receptor kinase in vitro requires cofactors such as protamine and poly(L-lysine), we examined the possibility that poly(L-lysine) may also potentiate the interaction between RAS proteins and the insulin receptor. We found that purified HRAS proteins are indeed phosphorylated by purified insulin receptor kinase in the presence of poly(L-lysine). In contrast, the KRAS protein, which carries an extremely basic domain (residues 172-182, Lys-Asp-Glu-Lys6-Ser-Arg), is phosphorylated by the receptor kinase without the addition of basic proteins. We then determined whether the KRAS basic domain peptide plays a role similar to that of poly(L-lysine) and found that both the HRAS protein and calmodulin are phosphorylated by the receptor kinase in the presence of the KRAS basic domain peptide. Further examination of the role of poly(L-lysine) in potentiating tyrosine phosphorylation of the HRAS protein and calmodulin by purified insulin receptor kinase indicates that poly(L-lysine) affects the conformation of these protein substrates as well as that of the receptor kinase domain. These studies suggest that polylysine-like basic proteins or domains are required to establish the interaction between insulin receptor kinase and its substrate.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2552437      PMCID: PMC298050          DOI: 10.1073/pnas.86.19.7306

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

1.  The monomeric alpha beta form of the insulin receptor exhibits much higher insulin-dependent tyrosine-specific protein kinase activity than the intact alpha 2 beta 2 form of the receptor.

Authors:  Y Fujita-Yamaguchi; S Kathuria
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

2.  Differential sensitivity of two functions of the insulin receptor to the associated proteolysis: kinase action and hormone binding.

Authors:  S Kathuria; S Hartman; C Grunfeld; J Ramachandran; Y Fujita-Yamaguchi
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Purification and characterization of human H-ras proteins expressed in Escherichia coli.

Authors:  M Gross; R W Sweet; G Sathe; S Yokoyama; O Fasano; M Goldfarb; M Wigler; M Rosenberg
Journal:  Mol Cell Biol       Date:  1985-05       Impact factor: 4.272

5.  The human insulin receptor cDNA: the structural basis for hormone-activated transmembrane signalling.

Authors:  Y Ebina; L Ellis; K Jarnagin; M Edery; L Graf; E Clauser; J H Ou; F Masiarz; Y W Kan; I D Goldfine
Journal:  Cell       Date:  1985-04       Impact factor: 41.582

6.  Homologies between signal transducing G proteins and ras gene products.

Authors:  J B Hurley; M I Simon; D B Teplow; J D Robishaw; A G Gilman
Journal:  Science       Date:  1984-11-16       Impact factor: 47.728

7.  Characterization of purified insulin receptor subunits.

Authors:  Y Fujita-Yamaguchi
Journal:  J Biol Chem       Date:  1984-01-25       Impact factor: 5.157

8.  Evidence against insulin-stimulated phosphorylation of calmodulin in 3T3-L1 adipocytes.

Authors:  P J Blackshear; D M Haupt
Journal:  J Biol Chem       Date:  1989-03-05       Impact factor: 5.157

9.  Purification of insulin receptor with full binding activity.

Authors:  Y Fujita-Yamaguchi; S Choi; Y Sakamoto; K Itakura
Journal:  J Biol Chem       Date:  1983-04-25       Impact factor: 5.157

10.  Characterization of the insulin receptor kinase purified from human placental membranes.

Authors:  M Kasuga; Y Fujita-Yamaguchi; D L Blithe; M F White; C R Kahn
Journal:  J Biol Chem       Date:  1983-09-25       Impact factor: 5.157

View more
  11 in total

1.  Control of src kinase activity by activators, inhibitors, and substrate chaperones.

Authors:  M Abdel-Ghany; K el-Gendy; S Zhang; E Racker
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

Review 2.  The biochemistry of ras p21.

Authors:  R J Grand; D Owen
Journal:  Biochem J       Date:  1991-11-01       Impact factor: 3.857

3.  Src promotes GTPase activity of Ras via tyrosine 32 phosphorylation.

Authors:  Severa Bunda; Pardeep Heir; Tharan Srikumar; Jonathan D Cook; Kelly Burrell; Yoshihito Kano; Jeffrey E Lee; Gelareh Zadeh; Brian Raught; Michael Ohh
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-25       Impact factor: 11.205

Review 4.  Calmodulin and PI3K Signaling in KRAS Cancers.

Authors:  Ruth Nussinov; Guanqiao Wang; Chung-Jung Tsai; Hyunbum Jang; Shaoyong Lu; Avik Banerjee; Jian Zhang; Vadim Gaponenko
Journal:  Trends Cancer       Date:  2017-02-18

5.  Heparin stimulates epidermal growth factor receptor-mediated phosphorylation of tyrosine and threonine residues.

Authors:  S Revis-Gupta; M Abdel-Ghany; J Koland; E Racker
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-15       Impact factor: 11.205

6.  Phosphorylation of calmodulin on Tyr99 selectively attenuates the action of calmodulin antagonists on type-I cyclic nucleotide phosphodiesterase activity.

Authors:  M K Saville; M D Houslay
Journal:  Biochem J       Date:  1994-05-01       Impact factor: 3.857

7.  Alteration of the kinetic properties of the epidermal growth factor receptor tyrosine kinase by basic proteins.

Authors:  L Hubler; P S Leventhal; P J Bertics
Journal:  Biochem J       Date:  1992-01-01       Impact factor: 3.857

8.  Growth-stimulatory monoclonal antibodies against human insulin-like growth factor I receptor.

Authors:  L Xiong; J Kasuya; S L Li; J Kato; Y Fujita-Yamaguchi
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

9.  Effect of synthetic peptides representing the hypervariable region of p21ras on Xenopus laevis oocyte maturation.

Authors:  I Soto-Cruz; A I Magee
Journal:  Biochem J       Date:  1995-02-15       Impact factor: 3.857

10.  Compartmentalization of PDGF on extracellular binding sites dependent on exon-6-encoded sequences.

Authors:  E W Raines; R Ross
Journal:  J Cell Biol       Date:  1992-01       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.